Aurobindo Pharma signs pact with Covaxx for Covid-19 vaccine

Aurobindo Pharma Ltd and Covaxx, a US-based company, have entered into an exclusive license agreement to develop, commercialise and manufacture UB-612, the first Multitope Peptide-based vaccine to fight Covid-19, for India and UNICEF.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3rlykYt